GleamWall
中文EN

ICUI ICU MEDICAL INC/DE

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 883984 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-5.9%
TTM net income YoY919.5%
TTM EPS YoY846.9%
Revenue 3-yr CAGR-1.0%
Net income 3-yr CAGR—

Margins

Gross margin40.3%
Operating margin5.1%
Net margin2.8%
FCF margin9.6%
EBITDA margin11.2%

Returns

ROE2.8%
ROA1.5%
ROIC (approx.)3.6%
Asset turnover0.54x

Leverage & solvency

Liabilities / assets44.4%
Debt / equity0.53x
Current ratio2.37x
Interest coverage1.41x

Cash quality & payout

Operating cash flow / net income4.63x
Accruals ratio-5.4%
Payout ratio—
Capex / revenue3.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$560.44M$551.68M$530.23M$540.70M$536.99M$548.87M$604.70M$629.80M
Cost of revenue$325.69M$316.63M$324.00M$337.72M$336.11M$340.80M$394.59M$402.55M
Gross profit$234.75M$235.05M$206.23M$202.99M$200.88M$208.06M$210.11M$227.26M
R&D expense$21.75M$22.70M$21.28M$21.09M$21.25M$21.87M$23.29M$22.36M
SG&A expense$154.41M$151.92M$154.57M$155.81M$152.77M$159.39M$157.23M$158.85M
Operating income$52.32M$39.13M$13.58M$5.63M$13.72M$10.59M$12.89M$37.69M
Interest expense$15.24M$15.75M$16.49M$30.95M$19.81M$20.55M$22.03M$34.24M
Pretax income$36.18M$23.14M-$3.98M-$15.90M-$2.51M$33.68M-$10.91M-$41.80M
Income tax$7.19M$7.07M-$34.71M-$2.65M-$658,000$1.18M$4.57M$32.05M
Net income$26.85M$19.09M$30.13M-$15.73M-$3.40M$35.34M-$15.48M-$23.83M
EBITDA$68.92M$55.73M$63.61M$56.46M$31.42M$27.49M$62.33M$90.68M
EPS (basic)1.070.761.22—-0.141.43-0.63—
EPS (diluted)1.070.761.20—-0.141.43-0.63—
Weighted avg. shares (diluted)25.14M25.04M25.18M—24.69M24.71M24.54M—
Balance sheet
Cash & equivalents$301.78M$298.30M$288.33M$307.96M$299.73M$300.02M$289.70M$308.57M
Short-term investments———————$0
Receivables$206.26M$183.53M$201.08M$180.51M$191.54M$179.50M$170.93M$182.83M
Inventory$607.27M$607.42M$605.59M$615.86M$622.44M$616.47M$590.33M$584.68M
Current assets$1.22B$1.21B$1.21B$1.19B$1.21B$1.18B$1.42B$1.44B
PP&E, net$444.99M$446.80M$445.13M$451.82M$455.97M$452.44M$441.98M$442.75M
Goodwill$1.48B$1.48B$1.49B$1.50B$1.50B$1.50B$1.46B$1.43B
Intangibles$536.47M$567.66M$598.97M$633.56M$664.83M$698.01M$716.67M$740.79M
Total assets$3.94B$3.97B$4.01B$4.05B$4.10B$4.11B$4.18B$4.20B
Current liabilities$514.63M$498.36M$517.90M$498.86M$492.90M$482.78M$549.02M$556.18M
Short-term debt$18.75M$18.75M$18.75M$18.75M$0$0$47.81M$51.00M
Long-term debt$1.13B$1.21B$1.26B$1.27B$1.31B$1.34B$1.49B$1.53B
Total debt$1.15B$1.23B$1.28B$1.28B$1.31B$1.34B$1.54B$1.58B
Total liabilities$1.75B$1.82B$1.90B$1.93B$1.98B$1.99B$2.20B$2.24B
Shareholders' equity$2.19B$2.15B$2.11B$2.12B$2.13B$2.12B$1.99B$1.97B
Net debt$850.07M$932.90M$992.25M$976.70M$1.01B$1.04B$1.25B$1.27B
Shares outstanding25.01M25.01M24.99M24.69M24.69M24.68M24.61M24.52M
Cash flow statement
Operating cash flow$99.59M$80.15M$38.91M$60.60M$56.71M$11.21M$51.33M$40.19M
Capital expenditure$16.19M$18.51M$11.30M$24.65M$29.08M$19.70M$14.62M$24.08M
Free cash flow$83.40M$61.64M$27.61M$35.95M$27.63M-$8.48M$36.71M$16.11M
Investing cash flow-$13.93M-$20.14M-$11.21M-$18.39M-$30.03M$187.46M-$16.81M-$26.55M
Financing cash flow-$80.97M-$50.23M-$44.12M-$34.48M-$25.69M-$195.01M-$56.34M-$8.19M
Depreciation & amortization$16.60M$16.60M$50.03M$50.83M$17.70M$16.90M$49.45M$52.99M
Stock-based compensation$11.86M$11.87M$14.01M$13.88M$15.24M$14.46M$12.18M$12.52M

Free plan shows the latest 8 periods; Pro shows all 75 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.